News ID: 279711
Published: 0357 GMT January 20, 2021

Health minister hopes for start of vaccination in coming weeks

Health minister hopes for start of vaccination in coming weeks
ISNA

Iran’s Health Minister Saeid Namaki hoped for the beginning of the coronavirus vaccination in the country in the coming weeks.

In a televised interview on Wednesday, Namaki expressed hope that the country would start coronavirus vaccinations before February 10. However, he emphasized that the ministry will not start the vaccination until it can bring the safest and most reliable vaccine into the country, according to IRNA.

President Hassan Rouhani said on Saturday that his government was doing its best to roll out a mass vaccination in two months, with priority given to medical workers and high-risk individuals.

Iran is under illegal sanctions imposed by the United States, which have hampered its access to medical equipment and pharmaceuticals and have complicated the process of importing vaccines from other countries.

Since the beginning of the coronavirus outbreak in the country in February, the country has been trying to produce a vaccine for the treatment of coronavirus patients while doing its utmost to also import reliable vaccines from other countries.

Iran launched human trials of its first domestic coronavirus vaccine late last month.

The vaccine, known as COViran Barekat, is being produced under the health protocols and guidelines announced by the Health Ministry.

A second domestic vaccine has also been approved by both the Iranian Food and Drug Administration and the Iranian National Committee for Ethics in Biomedical Research, Press TV reported.

If it passes the first phase successfully, the acceptable dose of the vaccine will be determined, and based on the results of Phase I, the second phase will begin with 500 people, according to the proposed protocol by the Razi Vaccine and Serum Research Institute.

Iran and Cuba are also working on the production of a coronavirus vaccine. The vaccine project, being jointly pursued by Iran and Cuba, has entered Phase II of its clinical trials, with no side effects having been reported so far.

The vaccine, known as Subrana 2, is now undergoing its human trials by the Cuban Finlay Institute and Iran’s Pasteur Institute.

The vaccine, which is the most advanced among Cuba’s four other coronavirus vaccines, has so far shown no side effects, as the initial stages of its testing have been completed successfully.

Health officials confirmed 6,182 new cases of COVID-19 infection from Tuesday to Wednesday, bringing the total caseload to 1,348,316.

Health Ministry spokeswoman Sima Sadat Lari said that 1,137,812 patients had so far recovered, but 4,214 remained in critical condition.

She also provided a daily death toll of 84.

 

 

 

   
KeyWords
 
Comments
Comment
Name:
Email:
Comment:
Security Key:
Captcha refresh
Page Generated in 0/0661 sec